Interferon Alfa-2b Injection Reference Listed Drug

* Please be kindly noted products are supplied for RLD supplies/ Reference listed drugs/ Comparator Drug Clinical trials. We do not sell to patients.

 

Name	Interferon alfa-2b Injection
Trade name	甘乐能IntronA
Specifications	1.8×107IU/1.2ml/branch;1branch/pack.
MAHolder	SPEurope
Original	Belgium

Indications of this product: Systemic administration Chronic hepatitis B: It is used to treat adults and children (≥ 1 year old) with compensated liver disease. The patient's serum HBsAg is positive for at least 6 months, and hepatitis B (hereinafter referred to as hepatitis B) virus (HBV) replication (serum) HBeAg positive) and serum alanine aminotransferase (ALT) increase. Before starting treatment with this product, it is recommended to perform a liver biopsy to confirm the degree of chronic hepatitis and liver damage. In a large number of clinical studies on the treatment of chronic hepatitis B with this product, the following standards have been adopted. Patients with chronic hepatitis B can be used as reference indicators before using this product: Chronic hepatitis C: This product is administered alone or in combination with ribavirin (ribavirin), which can relieve the disease in adult patients with chronic hepatitis C (hereinafter referred to as hepatitis C) with elevated liver enzymes without liver decompensation Activity level. Many studies conducted on these patients have shown that this product can normalize serum ALT, clear serum HCV-RNA, and improve liver histological lesions. The clinical experience of patients using this product for 12-18 months has shown that patients with a longer course of treatment have a higher sustained response rate than patients who stop taking the drug 6 months later. In a large number of clinical studies on chronic hepatitis C treated with this product, the following criteria have been adopted. Patients with chronic hepatitis C can be considered for reference before using this product: Chronic Hepatitis D: Treat patients with chronic hepatitis D (hereinafter referred to as liver D). Laryngeal papilloma: treatment of children or adults with laryngeal papilloma. Hairy cell leukemia: treatment of patients with hairy cell leukemia. Chronic myelogenous leukemia (CML): This product is administered alone or combined with cytarabine (Ara-C) to treat patients with chronic myelogenous leukemia. Thrombocythemia associated with chronic myeloid leukemia (CML): Thrombocythemia is often associated with CML. This product has been effective in the treatment of thrombocythemia related to CML. Multiple myeloma: For patients who have achieved substantial remission by induction therapy and relapsed patients, this product can be used as maintenance therapy. Non-Hodgkin’s lymphoma: combined with appropriate chemotherapy regimens, such as cyclophosphamide-hydroxydaunomycin-vincristine-prednisone (CHOP) chemotherapy regimens, this product can treat high tumor burden (stage III or IV) Follicular lymphoma. AIDS-related Kaposi's sarcoma: Treat patients with AIDS-related Kaposi's sarcoma. The patient has no history of opportunistic infections and CD4> 250/mm3. Renal cell carcinoma: treatment of patients with advanced renal cancer. Metastatic carcinoid tumor (endocrine pancreatic tumor): Treat patients with metastatic carcinoid tumor. Malignant melanoma: As an adjuvant treatment for adult melanoma patients who have no disease after surgery but are at high risk of recurrence. ""

Hot Tags: Interferon Alfa-2b Injection Reference Listed Drug, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock, Acarbose Tablets, Alfacalcidol Soft Capsules, Phenytoin Sodium Tablets, Adefovir Dipivoxil Tablets, Reference Listed Drugs, Argatroban Injection

• Previous: Dydrogesterone Tablets Reference Listed Drug
• Next: Emedastine Difumarate Eye Drops Reference Listed Drug